Management of the Axilla in T1-2 Breast Cancer Patients with Macrometastatic Sentinel Node Involvement Who Underwent Breast-Conserving Therapy

REFERENCES

• Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005;23:7703–7720.
   PubMed Web of Science ®Google Scholar
• Veronesi U, Viale G, Paganelli G, et al. Sentinel lymph node biopsy in breast cancer: Ten-year results of a randomized controlled study. Ann Surg. 2010;251:595–600.
   PubMed Web of Science ®Google Scholar
• Ivens D, Hoe AL, Podd TJ, et al. Assessment of morbidity from complete axillary dissection. Br J Cancer. 1992;66:136–138.
   PubMed Web of Science ®Google Scholar
• Ozaslan C, Kuru B. Lymphedema after treatment of breast cancer. Am J Surg. 2004;187:69–72.
   PubMed Web of Science ®Google Scholar
• Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: A randomized clinical trial. JAMA. 2011;305:569–575.
   PubMed Web of Science ®Google Scholar
• Giuliano AE, McCall L, Beitsch P, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: The American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg. 2010;252:426–432; discussion 432–3.
   PubMed Web of Science ®Google Scholar
• Dengel LT, Van Zee KJ, King TA, et al. Axillary dissection can be avoided in the majority of clinically node-negative patients undergoing breast-conserving therapy. Ann Surg Oncol. 2014;21:22–27.
   PubMed Web of Science ®Google Scholar
• Yi M, Kuerer HM, Mittendorf EA, et al. Impact of the American college of surgeons oncology group Z0011 criteria applied to a contemporary patient population. J Am Coll Surg. 2013;216:105–113.
   PubMed Web of Science ®Google Scholar
• Roberts A, Nofech-Mozes S, Youngson B, et al. The importance of applying ACOSOG Z0011 criteria in the axillary management of invasive lobular carcinoma: A multi-institutional cohort study. Ann Surg Oncol. 2015;22:3397–3401.
   PubMedGoogle Scholar
• Lyman GH, Somerfield MR, Bosserman LD, et al. Sentinel lymph node biopsy for patients with early-stage breast cancer: American society of clinical oncology clinical practice guideline update. J Clin Oncol. 2016;35:561–564.
   PubMed Web of Science ®Google Scholar
• Latosinsky S, Berrang TS, Cutter CS, et al. CAGS and ACS evidence based reviews in surgery. 40. Axillary dissection versus no axillary dissection in women with invasive breast cancer and sentinel node metastasis. Can J Surg. 2012;55:66–69.
   PubMed Web of Science ®Google Scholar
• Donker M, van Tienhoven G, Straver ME, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981–22023 AMAROS): A randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014;15:1303–1310.
   PubMed Web of Science ®Google Scholar
• Galimberti V, Cole BF, Zurrida S, et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): A phase 3 randomised controlled trial. Lancet Oncol. 2013;14:297–305. Erratum in: Lancet Oncol. 2013;14:e254.
   PubMed Web of Science ®Google Scholar
• Madsen EV, van Dalen J, van Gorp J, et al. Frozen section analysis of sentinel lymph nodes in patients with breast cancer does not impair the probability to detect lymph node metastases. Virchows Arch. 2012;460:69–76.
   PubMed Web of Science ®Google Scholar
• Fu MR. Breast cancer-related lymphedema: Symptoms, diagnosis, risk reduction, and management. World J Clin Oncol. 2014;5:241–247.
   PubMedGoogle Scholar
• Sávolt Á, Péley G, Polgár C, et al. Eight-year follow up result of the OTOASOR trial: The optimal treatment of the axilla–surgery or radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial. Eur J Surg Oncol. 2017;43:672–679.
   PubMed Web of Science ®Google Scholar
• Offersen BV, Nielsen HM, Overgaard M, et al. Is regional nodes radiotherapy an alternative to surgery? Breast. 2013;22(Suppl 2):S118–S128.
   PubMedGoogle Scholar
• Kuru B, Sullu Y, Yuruker S, et al. Factors predicting non-sentinel lymph node metastasis in T1-2 invasive breast cancer with 1–2 axillary sentinel lymph node metastases: Presentation of Ondokuz Mayis scoring system. J BUON. 2016;21:1129–1136. Erratum in: J BUON 2016;21:1571.
   PubMed Web of Science ®Google Scholar
• Meretoja TJ, Leidenius MH, Heikkilä PS, et al. International multicenter tool to predict the risk of nonsentinel node metastases in breast cancer. J Natl Cancer Inst. 2012;104:1888–1896.
   PubMedGoogle Scholar
• Chung MA, DiPetrillo T, Hernandez S, et al. Treatment of the axilla by tangential breast radiotherapy in women with invasive breast cancer. Am J Surg. 2002;184:401–402.
   PubMed Web of Science ®Google Scholar
• Rabinovitch R, Ballonoff A, Newman F, et al. Evaluation of breast sentinel lymph node coverage by standard radiation therapy fields. Int J Radiat Oncol Biol Phys. 2008;70:1468–1471.
   PubMed Web of Science ®Google Scholar
• Veronesi U, Orecchia R, Zurrida S, et al. Avoiding axillary dissection in breast cancer surgery: A randomized trial to assess the role of axillary radiotherapy. Ann Oncol. 2005;3:383–388.
   Google Scholar
• Whelan TJ, Olivotto IA, Parulekar WR, et al. Regional nodal irradiation in early-stage breast cancer. N Engl J Med. 2015;373:307–316.
   PubMed Web of Science ®Google Scholar
• Poortmans PM, Collette S, Kirkove C, et al. Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med. 2015;373:317–327.
   PubMed Web of Science ®Google Scholar
• Shaitelman SF, Chiang YJ, Griffin KD, et al. Radiation therapy targets and the risk of breast cancer-related lymphedema: A systematic review and network meta-analysis. Breast Cancer Res Treat. 2017;162:201–215. Erratum in: Breast Cancer Res Treat. 2017;162:217.
   PubMed Web of Science ®Google Scholar
• Sanuki N, Takeda A, Amemiya A, et al. Outcomes of clinically node-negative breast cancer without axillary dissection: Can preserved axilla be safely treated with radiation after a positive sentinel node biopsy? Clin Breast Cancer. 2013;13:69–76.
   PubMed Web of Science ®Google Scholar